Ani Pharmaceuticals (ANIP) Total Debt Growth (3y) (2015 - 2026)
Ani Pharmaceuticals (ANIP) Total Debt Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 92.83% |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | -0.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.95% |
| Mar 31, 2026 | 2.16% |
| Dec 31, 2025 | 2.66% |
| Sep 30, 2025 | 2.96% |
| Jun 30, 2025 | 1.72% |
| Mar 31, 2025 | 3.29% |
| Dec 31, 2024 | 3.46% |
| Sep 30, 2024 | 15.87% |
| Jun 30, 2024 | 11.69% |
| Mar 31, 2024 | 15.83% |
| Dec 31, 2023 | 16.96% |
| Sep 30, 2023 | 15.01% |
| Jun 30, 2023 | 14.58% |
| Mar 31, 2023 | 12.71% |
| Dec 31, 2022 | 15.43% |
| Sep 30, 2022 | 60.75% |
| Jun 30, 2022 | 60.17% |
| Mar 31, 2022 | 60.28% |
| Dec 31, 2021 | 59.70% |
| Sep 30, 2021 | 41.27% |